ASND vs AVGO Stock Comparison

ASND currently leads AVGO in this stock comparison, with AIQ scores of 72 vs 52. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 20 points
ASND
Healthcare
vs
AVGO
Technology
ASND
Ascendis Pharma A/S
Leads
Price
$275
Day move
+3.12%
AIQ Score
72/100
Best edge
Momentum
Sector
Healthcare
AVGO
Broadcom Inc.
Price
$347
Day move
-4.76%
AIQ Score
52/100
Best edge
Balanced
Sector
Technology

What is the main difference between ASND and AVGO?

ASND leads the current stock comparison as Ascendis Pharma A/S, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Ascendis Pharma A/S vs Broadcom Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

ASND leads

ASND leads by 20 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 6 points over 30 sessions. Wall Street currently favors AVGO on target upside.

Competitive: 4 of 6 evidence groups support ASND, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
ASND

Ascendis Pharma A/S

Leads
AIQ Score
72/100
AIQ Edge Score
9/10
AVGO

Broadcom Inc.

AIQ Score
52/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors ASND over AVGO, 72 versus 52 as of Nov 15, 2026. ASND's advantage is driven primarily by stronger momentum and risk resilience. ASND also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 4 of 6 covered evidence groups favor ASND today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. ASND lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions.

Compare Ascendis Pharma A/S and Broadcom Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ASND
+77.7%
AVGO
+565.5%

Total return comparison

Growth of $10,000, distributions reinvested

ASND $17,772 · AVGO $66,548

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ASND and AVGO against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ASND advantage
0
AVGO advantage
  • Momentum75 vs 40
    ASND +35
  • Risk Resilience72 vs 47
    ASND +25
  • Value66 vs 50
    ASND +16
  • Quality71 vs 69
    Even

4 of 6 evidence groups favor ASND. ASND’s edge is concentrated in momentum and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ASND+2 AIQ

Largest factor move: Value +4

New signals

  • 52-Week High Proximity — bullish, risk_regime, long horizon (1.3%)
  • BB Upper Band Breach — bearish, volatility, short horizon
AVGO0 AIQ

Largest factor move: Momentum -2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

ASND's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — ASND and AVGO both carry a full feed there.

The central trade-off

ASND (Ascendis Pharma A/S): the stronger current systematic profile, led by momentum and risk resilience.

AVGO (Broadcom Inc.): the counter-case, on fundamentals, analyst expectations — but at materially higher volatility, 70% against 22.3%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ASND

ASND on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

ASND

ASND on the peer-relative Value factor, by 16 points.

Momentum

ASND

ASND on the Momentum factor, by 35 points.

Lower downside

ASND

ASND on Risk Resilience, by 25 points.

Analyst upside

AVGO

AVGO on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ASND, analyst targets favor AVGO. That disagreement is the most useful thing on this page.

MeasureASNDAVGONote
Implied upside to target+13.2%+48.5%AVGO has more room
Target dispersion+27%+48.5%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2251Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor ASND. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreASND72 vs 52
FundamentalsAVGOon balancerevenue growth 6.5% vs 33.4%; EPS growth -66.1% vs 40.3%; TTM ROE 4.8% vs 13.1%; gross margin 90.6% vs 68.8%; operating margin 18.4% vs 48.4% — AVGO takes 4 of 5 decided legs, not all of them
ValuationASNDValue 66 vs 50
TechnicalsASNDPrice vs 50-day 13.5% vs 0.5%; vs 200-day 14.8% vs -5.6%
Risk ResilienceASNDRisk Resilience 72 vs 47
Analyst expectationsAVGOTarget upside 13.2% vs 48.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ASND and AVGO and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 20 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ASND.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ASND lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions.

May 27ASND leads above the line · AVGO leads belowNov 13
Today
ASND +20
72 vs 52
7 sessions ago
ASND +19
69 vs 50
30 sessions ago
ASND +6
61 vs 55
90 sessions ago
ASND +7
66 vs 59

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ASNDConflicted

8 bullish / 2 bearish / 1 neutral, conflicted

Only ASND

  • Golden Cross Active — bullish, trend, long horizon (1.18%)
  • 52-Week High Proximity — bullish, risk_regime, long horizon (1.3%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • BB Upper Band Breach — bearish, volatility, short horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
AVGOConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • Death Cross Active — bearish, trend, long horizon (6.38%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
  • Beta Spike Warning — bearish, risk_regime, long horizon

Both carry 2 more signals that do not separate them: Accumulation Pattern, MACD Histogram Expanding Bullish.

ASND leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ASNDConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +3.12%, AIQ +2 points).

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Momentum gap — currently 35 points behind, the largest single contributor to ASND's edge.
  2. 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ASND's conflicting signal state resolves bearish — it currently carries 8 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricASNDAVGO
Revenue growth (YoY)6.5%33.4%
EPS growth (YoY)-66.1%40.3%
Gross margin90.6%68.8%
Operating margin18.4%48.4%
Return on equity (TTM)4.8%13.1%
Debt to equity0.30.6

Performance

ASND leads 5 of 6 windows
MetricASNDAVGO
1 week (5 sessions)7.2%18.2%
1 month (20 sessions)22.3%5.6%
3 months (63 sessions)11.3%-11.6%
6 months (126 sessions)14.5%-18.4%
Year to date29.1%0.3%
1 year (252 sessions)38.2%-2.3%

Technicals

ASND has the stronger structure
MetricASNDAVGO
RSI (14)74.753.2
ADX (14)37.923
Price vs 50-day13.5%0.5%
Price vs 200-day14.8%-5.6%
Volatility (1M, annualized)22.3%70%

Risk

ASND is the more resilient
MetricASNDAVGO
Beta0.42.21
Sharpe ratio0.840.21
Sortino ratio1.270.29
Max drawdown-19.7%-39.5%
Current drawdown-0.6%-27.9%
Annualized volatility38.6%48.6%
Value at risk (95%)-3.6%-4.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ASND or AVGO?

On the Algovestiq AIQ Score, ASND is the stronger of the two as of Nov 15, 2026, scoring 72 against AVGO's 52. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ASND or AVGO the better buy right now?

ASND carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor ASND over AVGO?

The composite weights Quality, Value, Momentum and Risk Resilience. ASND leads Momentum by 35 points; ASND leads Risk Resilience by 25 points; ASND leads Value by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ASND or AVGO?

Analyst price targets imply +13.2% upside for ASND and +48.5% for AVGO, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors ASND. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ASND or AVGO?

ASND is the better-valued of the two on the peer-relative Value factor. ASND on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ASND or AVGO?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ASND or AVGO?

ASND on the Momentum factor, by 35 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ASND or AVGO?

ASND is the more resilient of the two, so the other name carries the higher downside risk. ASND on Risk Resilience, by 25 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ASND more profitable than AVGO?

The profitability evidence is mixed: gross margin 90.6% vs 68.8%; operating margin 18.4% vs 48.4%; ttm roe 4.8% vs 13.1%. ASND leads on one measure and AVGO on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is ASND's lead over AVGO getting stronger or weaker?

ASND lead: Strengthening — the AIQ differential moved from 6 to 20 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ASND vs AVGO verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Momentum gap — currently 35 points behind, the largest single contributor to ASND's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; ASND's conflicting signal state resolves bearish — it currently carries 8 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ASND and AVGO?

ASND: 8 bullish / 2 bearish / 1 neutral, conflicted. AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ASND is Golden Cross Active (bullish, long horizon). On AVGO it is Death Cross Active (bearish, long horizon).

Compare ASND and AVGO with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.